Join
Live feed
·
PRReleasevia Quantisnow
Ascendis Pharma A/S logo

Children with Achondroplasia Treated with TransCon CNP Showed Continued Improvements in Lower Extremity Alignment at Week 104 of the Pivotal ApproaCH Trial

ByQuantisnow·Wall Street's wire, on your screen.
ASND· Ascendis Pharma A/S
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ASND (Ascendis Pharma A/S) and more on Quantisnow.